MLYS

13.7003.25%
AS

Adam Scott Levy

CFO & Secretary

Mr. Adam Scott Levy serves as Chief Financial Officer at Mineralys Therapeutics, Inc. since March 2022 and serves as its Secretary since January 2023 and served as its Chief Business Officer since March 2022. Mr. Levy served as Chief Financial Officer of Sanifit Therapeutics S.A. since August 20, 2020. He served as Chief Business Officer of Brickell Biotech, Inc since August 2019 until August 2020. He served as Chief Business Officer of Miragen Therapeutics, Inc. since February 2017 until July 26, 2019. Prior to joining Miragen Therapeutics, Mr. Levy served as Private Miragen’s Chief Business Officer since May 1, 2016. Mr. Levy has over 16 years of advisory experience primarily in the life sciences sector to miRagen. Prior to joining Private Miragen, Mr. Levy served as a Senior Vice President of Healthcare Investment Banking at Wedbush Securities Inc. from September 2013 to May 2016. From May 2011 to August 2012, Mr. Levy was employed by Merrill Lynch, Pierce, Fenner & Smith, Incorporated as Vice President of Healthcare Investment Banking. Prior to joining Merrill Lynch, Mr. Levy served as Vice President of Healthcare Investment Banking at Wedbush from October 2009 through April 2011. Between 2000 through 2009, Between 2000 and 2016, Mr. Levy held multiple investment banking positions at Merrill Lynch, Pierce, Fenner & Smith, and Jefferies Group. Mr. Levy holds a Bachelor of Science in Business Management and Marketing, Magna Cum Laude, from the Dyson School of Applied Economics and Management, Cornell University.

Positions